Oberon Investments Group PLC
13 July 2026
13 July 2026
('Oberon', the 'Company', or the 'Group')
Directorate Change
Oberon Investments Group plc (AQSE: OBE), the boutique investment management, wealth planning and corporate broking group, is pleased to announce the proposed appointment of Jonathan Eddis as a Non-Executive Director, subject to completion of the Company's customary due diligence and background checks.
Jonathan brings significant board, financial services and strategic advisory experience. He is currently an Adviser to Rothschild & Co. and a Non-Executive Director of Covéa Insurance UK, where he chairs the Remuneration Committee and Investment Committee and sits on the Audit and Risk Committee. Prior to this, Jonathan spent 37 years at Rothschild & Co., most recently as Managing Director and Co-Head of UK Financial Institutions, advising clients on a broad range of strategic and corporate finance transactions. He also holds a number of charitable board appointments and previously served as a Director of Weatherbys Bank Limited. Jonathan is a qualified chartered accountant, having trained with KPMG and qualified as an ACA in 1985.
The Group also announces that Mark Ibbotson will step down from the Board as a Non-Executive Director with effect from 31 July 2026, after four years in the role, due to his increasing commitments outside Oberon. Mark will work closely with the Board to support an orderly transition.
Simon McGivern, CEO of Oberon, commented:
"On behalf of everyone at Oberon, I would like to thank Mark for his contribution to the Board over the past four years. Mark has provided valued support, insight and challenge during an important period in the Group's development, and we wish him well for the future.
On behalf of the Oberon Group, we are very pleased that Jonathan will be joining the Board. Jonathan brings extensive experience across financial services, governance and corporate transactions, which will be a valuable addition to the Board. We are also pleased to welcome Barry Smead to the Board as Group Chief Operating Officer, reflecting the continued strengthening of the Group's leadership and governance framework."
Mark Ibbotson commented:
"I have greatly enjoyed my time on the Board of Oberon and working with the wider team across the Group. It has been a period of significant development for the business and I am proud of what Oberon has achieved during that time. I would like to thank my fellow Board members and colleagues across the Group for their support and wish Oberon every success for the future."
Jonathan Eddis commented:
"I am delighted to be joining Oberon and to have the opportunity to work with Simon and the Board. The Group has made meaningful progress in recent years and I look forward to supporting the business as it continues to develop."
Further to the Company's announcement of 14 April 2026 regarding the appointment of Barry Smead as Group Chief Operating Officer and Executive Director of the Board, subject to FCA approval, Oberon confirms that FCA approval has now been received and the appointment will take effect on 1 August 2026. With effect from the same date, Adam Herringer will assume the role of Chief Strategy and Transformation Officer and remain an Executive Director of the Board.
The directors of Oberon accept responsibility for this announcement.
Enquiries:
|
Oberon Investments |
+44 (0)20 3179 5300
|
|
Strand Hanson Limited (AQSE Corporate Adviser to the Company) Ritchie Balmer / James Spinney / Imogen Ellis |
+44 (0)20 7409 3494
|
|
Oberon Capital (Broker to the Company) Mike Seabrook / Nick Lovering |
+44 (0)20 3179 5300 |
|
Camarco (Financial PR Adviser to the Company) Ed Gascoigne-Pees / Julia Tilley / Rachel Scott
|
oberoninvestments@camarco.co.uk +44 (0)7815 068 387 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.